Difference between revisions of "V-HeFT Trial"
From Gomerpedia
| Line 2: | Line 2: | ||
The '''V-HeFT Trial''', which stands for '''very hefty''', was a clinical trial published in the ''[[New England Journal of Medicine]]'' establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. Hefty findings indeed. Especially in an era before [[ACE Inhibitor|ACEI inhibitors]], ACE bandages, and beta blockers like [[Metoprolol|metoprolol]]. | The '''V-HeFT Trial''', which stands for '''very hefty''', was a clinical trial published in the ''[[New England Journal of Medicine]]'' establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. Hefty findings indeed. Especially in an era before [[ACE Inhibitor|ACEI inhibitors]], ACE bandages, and beta blockers like [[Metoprolol|metoprolol]]. | ||
| + | |||
| + | |||
| + | '''Other Conditions or Trials''' | ||
| + | ---- | ||
| + | * [[ACE Inhibitor]] | ||
| + | * [[ACE Bandage]] | ||
| + | * [[Beta Block Party]] | ||
| + | * [[Metoprolol]] | ||
| + | * [[TRICC Trial]] | ||
| + | * [[V-Fib]] | ||
| + | * [[V-Tach]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
| + | [[Category:Medical Journals, Textbooks & Other Resources]] | ||
Latest revision as of 17:38, 5 August 2017
The V-HeFT Trial, which stands for very hefty, was a clinical trial published in the New England Journal of Medicine establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. Hefty findings indeed. Especially in an era before ACEI inhibitors, ACE bandages, and beta blockers like metoprolol.
Other Conditions or Trials
|
Fun Stuff
|
